UNSPSC 85492615: Revision of autologous tissue substitute in heart, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in heart, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WAX7Z

UNSPSC 85492615 Revision of autologous tissue substitute in heart, external approach is a Commodity code that shows no substantive alignment with recent state and local procurement activity. The code's technical name describes a specific cardiac surgical procedure involving the replacement of autologous tissue, yet the six recent opportunities posted under this code span independent medical evaluation services for public-sector retirement disability determinations, surgical benefit carve-out management for municipal employee health plans, occupational medical surveillance for ferry system employees, emergency and specialty healthcare services for detained youth, pharmacy benefit management administration, and temporary health professional staffing—none of which involve cardiac tissue revision or autologous grafting procedures. This mismatch suggests either systematic miscoding in state and local procurement systems or that the code is being applied as a catchall for health services rather than reserved for its intended cardiac-surgical commodity scope.

Recent opportunities originated across four states and multiple issuing-body types: the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation (Washington), Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). The Phoenix and Long Beach opportunities closed in October 2026; the WSDOT occupational surveillance RFP closes October 9, 2026 with apparent bidder announcement scheduled October 20, 2026. None of these solicitations target the cardiac surgical or tissue-replacement market that the code nominally describes. The code appears dormant for its stated purpose in state and local procurement.